Clinical Development Programme of the Innovative Mesenchymal Stromal Cell Product MSC-FFM/MC0518 for Steroid-Refractory Acute Graft-Versus-Host Disease: Design of 2 Randomised Controlled Trials in Adult and Paediatric Patients
<p>Introduction: Acute graft-versus-host disease (aGvHD) is a potentially life-threatening complication that can occur following allogeneic haematopoietic stem cell transplantation. Although corticosteroids remain the standard first-line therapy, a considerable number of patients fail to...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Karger Publishers
2026-01-01
|
| シリーズ: | Transfusion Medicine and Hemotherapy |
| オンライン・アクセス: | https://karger.com/article/doi/10.1159/000550469 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
